Changes in thymosin-α1 content in patients with nonspecific gynecologic diseases depending on inflammation type and efficacy of antiinflammatory and immunomodulating therapy

In: Bulletin of Experimental Biology and Medicine · 2000 · vol. 130(3) , pp. 895–897 · doi:10.1007/bf02682263 · W4251772246
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
AI-generated summary by gemini-2.5-flash-lite, 2026-08-10

This study investigated changes in thymosin-α1 levels in patients with nonspecific gynecologic diseases, analyzing how these changes correlated with inflammation type and the effectiveness of anti-inflammatory and immunomodulating therapies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (8)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-08-21T06:37:11.537704+00:00
License: CC0 · commercial use OK